1 citations · 1 across the 1 of their papers we have counts for
1 paper
David Glynn, Pedro Saramago, Janharpreet Singh +4
A growing number of oncology treatments, such as bevacizumab, are used across multiple indications. However, in health technology assessment (HTA), their clinical and cost-effectiv…